Literature DB >> 3343522

Experimental Campylobacter jejuni infection in humans.

R E Black1, M M Levine, M L Clements, T P Hughes, M J Blaser.   

Abstract

Two strains of Campylobacter jejuni ingested by 111 adult volunteers, in doses ranging from 8 x 10(2) to 2 x 10(9) organisms, caused diarrheal illnesses. Rates of infection increased with dose, but development of illness did not show a clear dose relation. Resulting illnesses with strain A3249 ranged from a few loose stools to dysentery, with an average of five diarrheal stools and a volume of 509 mL. Infection with strain 81-176 was more likely to cause illness, and these illnesses were more severe, with an average of 15 stools and 1484 mL of total stool volume. All patients had fecal leukocytes. The dysenteric nature of the illness indicates that the pathogenesis of C. jejuni infection includes tissue inflammation. Ill volunteers developed a serum antibody response to the C. jejuni group antigen and were protected from subsequent illness but not infection with the same strain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3343522     DOI: 10.1093/infdis/157.3.472

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  335 in total

1.  Increase in acid tolerance of Campylobacter jejuni through coincubation with amoebae.

Authors:  Diana Axelsson-Olsson; Lovisa Svensson; Jenny Olofsson; Paulo Salomon; Jonas Waldenström; Patrik Ellström; Björn Olsen
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

2.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Development and Evaluation of CmeC Subunit Vaccine against Campylobacter jejuni.

Authors:  Ximin Zeng; Fuzhou Xu; Jun Lin
Journal:  J Vaccines Vaccin       Date:  2010-01-01

4.  Prevalence, development, and molecular mechanisms of bacteriocin resistance in Campylobacter.

Authors:  Ky Van Hoang; Norman J Stern; Arnold M Saxton; Fuzhou Xu; Ximin Zeng; Jun Lin
Journal:  Appl Environ Microbiol       Date:  2011-01-28       Impact factor: 4.792

5.  Identification and characterization of a lipopolysaccharide α,2,3-sialyltransferase from the human pathogen Helicobacter bizzozeronii.

Authors:  Pradeep Kumar Kondadi; Mirko Rossi; Brigitte Twelkmeyer; Melissa J Schur; Jianjun Li; Thomas Schott; Lars Paulin; Petri Auvinen; Marja-Liisa Hänninen; Elke K H Schweda; Warren Wakarchuk
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

6.  A deep-rough mutant of Campylobacter jejuni 81-176 is noninvasive for intestinal epithelial cells.

Authors:  Margaret I Kanipes; Lindsay C Holder; Adrian T Corcoran; Anthony P Moran; Patricia Guerry
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

7.  Adhesion to and invasion of HEp-2 cells by Campylobacter spp.

Authors:  M E Konkel; L A Joens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Experimental Campylobacter jejuni infection in Macaca nemestrina.

Authors:  R G Russell; M J Blaser; J I Sarmiento; J Fox
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Identification of the enteropathogens Campylobacter jejuni and Campylobacter coli based on the cadF virulence gene and its product.

Authors:  M E Konkel; S A Gray; B J Kim; S G Garvis; J Yoon
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Selective biochemical labeling of Campylobacter jejuni cell-surface glycoconjugates.

Authors:  Garrett E Whitworth; Barbara Imperiali
Journal:  Glycobiology       Date:  2015-03-11       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.